g45ebo9 | Knowledge4COVID-19

Property	Value
?:creator	<https://research.tib.eu/covid-19/entity/Ghasemnejad-Berenji%2C_Morteza%3B_Pashapour%2C_Sarvin>
?:doi	10.1159/000511280
?:doi	<https://research.tib.eu/covid-19/entity/10.1159/000511280>
?:journal	Pharmacology
?:license	no-cc
?:pdf_json_files	document_parses/pdf_json/e3cd2a07ba3cc0842c648d76f4a0e303c61c091d.json
?:pmc_json_files	document_parses/pmc_json/PMC7573895.xml.json
?:pmcid	<https://research.tib.eu/covid-19/entity/PMC7573895>
?:pmid	<https://research.tib.eu/covid-19/entity/33011728.0>
?:pmid	33011728.0
?:publication_isRelatedTo_Disease	<https://research.tib.eu/covid-19/entity/COVID-19>
?:sha_id	<https://research.tib.eu/covid-19/entity/e3cd2a07ba3cc0842c648d76f4a0e303c61c091d>
?:source	Medline; PMC
?:title	SARS-CoV-2 and the Possible Role of Raf/MEK/ERK Pathway in Viral Survival: Is This a Potential Therapeutic Strategy for COVID-19?
?:type	<https://research.tib.eu/covid-19/vocab/Publication>
?:year	2020-10-02

Metadata

Anon_0

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://purl.org/net/provenance/ns#DataItem>

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://www.w3.org/2004/03/trix/rdfg-1/Graph>

<http://xmlns.com/foaf/0.1/primaryTopic>

<https://research.tib.eu/covid-19/entity/1g45ebo9>

<http://xmlns.com/foaf/0.1/topic>

Anon_0

<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes>

<https://research.tib.eu/covid-19/data/entity/1g45ebo9>

<http://purl.org/net/provenance/ns#createdBy>

Anon_1 (more)

expand all